A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin

por Fan, Dengxuan, Yang, Hailing, Mao, Weiqun, Rask, Philip J., Pang, Lan, Xu, Congjian, Vankayalapat, Hariprasad, Ahmed, Ahmed A., Bast, Robert C., Lu, Zhen
Publicado 2021

DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1

por Sutton, Margie N., Huang, Gilbert Y., Liang, Xiaowen, Sharma, Rajesh, Reger, Albert S., Mao, Weiqun, Pang, Lan, Rask, Philip J., Lee, Kwangkook, Gray, Joshua P., Hurwitz, Amy M., Palzkill, Timothy, Millward, Steven W., Kim, Choel, Lu, Zhen, Bast, Robert C.
Publicado 2019

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

por Lu, Zhen, Mao, Weiqun, Yang, Hailing, Santiago-O’Farrill, Janice M., Rask, Philip J., Mondal, Jayanta, Chen, Hu, Ivan, Cristina, Liu, Xiuping, Liu, Chang-Gong, Xi, Yuanxin, Masuda, Kenta, Carrami, Eli M., Chen, Meng, Tang, Yitao, Pang, Lan, Lakomy, David S., Calin, George A., Liang, Han, Ahmed, Ahmed A., Vankayalapati, Hariprasad, Bast, Robert C.
Publicado 2022